Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Treatment for Gastroparesis market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Treatment for Gastroparesis industry.
Based on our recent survey, we have several different scenarios about the Treatment for Gastroparesis YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Treatment for Gastroparesis will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment for Gastroparesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment for Gastroparesis market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Treatment for Gastroparesis market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each sales channel segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Treatment for Gastroparesis market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Treatment for Gastroparesis market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each sales channel segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Treatment for Gastroparesis market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment for Gastroparesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment for Gastroparesis market.
The following manufacturers are covered in this report:
Janssen Global Services
Evoke Pharma
Cardinal Health
Salix Pharmaceuticals
Alfa Wassermann
Abbott Laboratories
Medtronic
C.R.Bard
Rhythm Pharmaceuticals
Boston Scientific
Kimberly-Clark
Treatment for Gastroparesis Breakdown Data by Type
Drugs
Surgical Treatment Products
Treatment for Gastroparesis Breakdown Data by Sales Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
1 Study Coverage
1.1 Treatment for Gastroparesis Product Introduction
1.2 Market Segments
1.3 Key Treatment for Gastroparesis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Treatment for Gastroparesis Market Size Growth Rate by Type
1.4.2 Drugs
1.4.3 Surgical Treatment Products
1.5 Market by Sales Channel
1.5.1 Global Treatment for Gastroparesis Market Size Growth Rate by Sales Channel
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): Treatment for Gastroparesis Industry Impact
1.6.1 How the Covid-19 is Affecting the Treatment for Gastroparesis Industry
1.6.1.1 Treatment for Gastroparesis Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Treatment for Gastroparesis Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Treatment for Gastroparesis Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Treatment for Gastroparesis Market Size Estimates and Forecasts
2.1.1 Global Treatment for Gastroparesis Revenue 2015-2026
2.1.2 Global Treatment for Gastroparesis Sales 2015-2026
2.2 Treatment for Gastroparesis Market Size by Region: 2020 Versus 2026
2.2.1 Global Treatment for Gastroparesis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Treatment for Gastroparesis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Treatment for Gastroparesis Competitor Landscape by Players
3.1 Treatment for Gastroparesis Sales by Manufacturers
3.1.1 Treatment for Gastroparesis Sales by Manufacturers (2015-2020)
3.1.2 Treatment for Gastroparesis Sales Market Share by Manufacturers (2015-2020)
3.2 Treatment for Gastroparesis Revenue by Manufacturers
3.2.1 Treatment for Gastroparesis Revenue by Manufacturers (2015-2020)
3.2.2 Treatment for Gastroparesis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Treatment for Gastroparesis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Treatment for Gastroparesis Revenue in 2019
3.2.5 Global Treatment for Gastroparesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Treatment for Gastroparesis Price by Manufacturers
3.4 Treatment for Gastroparesis Manufacturing Base Distribution, Product Types
3.4.1 Treatment for Gastroparesis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Treatment for Gastroparesis Product Type
3.4.3 Date of International Manufacturers Enter into Treatment for Gastroparesis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Treatment for Gastroparesis Market Size by Type (2015-2020)
4.1.1 Global Treatment for Gastroparesis Sales by Type (2015-2020)
4.1.2 Global Treatment for Gastroparesis Revenue by Type (2015-2020)
4.1.3 Treatment for Gastroparesis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Treatment for Gastroparesis Market Size Forecast by Type (2021-2026)
4.2.1 Global Treatment for Gastroparesis Sales Forecast by Type (2021-2026)
4.2.2 Global Treatment for Gastroparesis Revenue Forecast by Type (2021-2026)
4.2.3 Treatment for Gastroparesis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Treatment for Gastroparesis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Sales Channel (2015-2026)
5.1 Global Treatment for Gastroparesis Market Size by Sales Channel (2015-2020)
5.1.1 Global Treatment for Gastroparesis Sales by Sales Channel (2015-2020)
5.1.2 Global Treatment for Gastroparesis Revenue by Sales Channel (2015-2020)
5.1.3 Treatment for Gastroparesis Price by Sales Channel (2015-2020)
5.2 Treatment for Gastroparesis Market Size Forecast by Sales Channel (2021-2026)
5.2.1 Global Treatment for Gastroparesis Sales Forecast by Sales Channel (2021-2026)
5.2.2 Global Treatment for Gastroparesis Revenue Forecast by Sales Channel (2021-2026)
5.2.3 Global Treatment for Gastroparesis Price Forecast by Sales Channel (2021-2026)
6 North America
6.1 North America Treatment for Gastroparesis by Country
6.1.1 North America Treatment for Gastroparesis Sales by Country
6.1.2 North America Treatment for Gastroparesis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Treatment for Gastroparesis Market Facts & Figures by Type
6.3 North America Treatment for Gastroparesis Market Facts & Figures by Sales Channel
7 Europe
7.1 Europe Treatment for Gastroparesis by Country
7.1.1 Europe Treatment for Gastroparesis Sales by Country
7.1.2 Europe Treatment for Gastroparesis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Treatment for Gastroparesis Market Facts & Figures by Type
7.3 Europe Treatment for Gastroparesis Market Facts & Figures by Sales Channel
8 Asia Pacific
8.1 Asia Pacific Treatment for Gastroparesis by Region
8.1.1 Asia Pacific Treatment for Gastroparesis Sales by Region
8.1.2 Asia Pacific Treatment for Gastroparesis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Treatment for Gastroparesis Market Facts & Figures by Type
8.3 Asia Pacific Treatment for Gastroparesis Market Facts & Figures by Sales Channel
9 Latin America
9.1 Latin America Treatment for Gastroparesis by Country
9.1.1 Latin America Treatment for Gastroparesis Sales by Country
9.1.2 Latin America Treatment for Gastroparesis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Treatment for Gastroparesis Market Facts & Figures by Type
9.3 Central & South America Treatment for Gastroparesis Market Facts & Figures by Sales Channel
10 Middle East and Africa
10.1 Middle East and Africa Treatment for Gastroparesis by Country
10.1.1 Middle East and Africa Treatment for Gastroparesis Sales by Country
10.1.2 Middle East and Africa Treatment for Gastroparesis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Treatment for Gastroparesis Market Facts & Figures by Type
10.3 Middle East and Africa Treatment for Gastroparesis Market Facts & Figures by Sales Channel
11 Company Profiles
11.1 Janssen Global Services
11.1.1 Janssen Global Services Corporation Information
11.1.2 Janssen Global Services Description, Business Overview and Total Revenue
11.1.3 Janssen Global Services Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Janssen Global Services Treatment for Gastroparesis Products Offered
11.1.5 Janssen Global Services Recent Development
11.2 Evoke Pharma
11.2.1 Evoke Pharma Corporation Information
11.2.2 Evoke Pharma Description, Business Overview and Total Revenue
11.2.3 Evoke Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Evoke Pharma Treatment for Gastroparesis Products Offered
11.2.5 Evoke Pharma Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Corporation Information
11.3.2 Cardinal Health Description, Business Overview and Total Revenue
11.3.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cardinal Health Treatment for Gastroparesis Products Offered
11.3.5 Cardinal Health Recent Development
11.4 Salix Pharmaceuticals
11.4.1 Salix Pharmaceuticals Corporation Information
11.4.2 Salix Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Salix Pharmaceuticals Treatment for Gastroparesis Products Offered
11.4.5 Salix Pharmaceuticals Recent Development
11.5 Alfa Wassermann
11.5.1 Alfa Wassermann Corporation Information
11.5.2 Alfa Wassermann Description, Business Overview and Total Revenue
11.5.3 Alfa Wassermann Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Alfa Wassermann Treatment for Gastroparesis Products Offered
11.5.5 Alfa Wassermann Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Corporation Information
11.6.2 Abbott Laboratories Description, Business Overview and Total Revenue
11.6.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Abbott Laboratories Treatment for Gastroparesis Products Offered
11.6.5 Abbott Laboratories Recent Development
11.7 Medtronic
11.7.1 Medtronic Corporation Information
11.7.2 Medtronic Description, Business Overview and Total Revenue
11.7.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Medtronic Treatment for Gastroparesis Products Offered
11.7.5 Medtronic Recent Development
11.8 C.R.Bard
11.8.1 C.R.Bard Corporation Information
11.8.2 C.R.Bard Description, Business Overview and Total Revenue
11.8.3 C.R.Bard Sales, Revenue and Gross Margin (2015-2020)
11.8.4 C.R.Bard Treatment for Gastroparesis Products Offered
11.8.5 C.R.Bard Recent Development
11.9 Rhythm Pharmaceuticals
11.9.1 Rhythm Pharmaceuticals Corporation Information
11.9.2 Rhythm Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Rhythm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Rhythm Pharmaceuticals Treatment for Gastroparesis Products Offered
11.9.5 Rhythm Pharmaceuticals Recent Development
11.10 Boston Scientific
11.10.1 Boston Scientific Corporation Information
11.10.2 Boston Scientific Description, Business Overview and Total Revenue
11.10.3 Boston Scientific Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Boston Scientific Treatment for Gastroparesis Products Offered
11.10.5 Boston Scientific Recent Development
11.1 Janssen Global Services
11.1.1 Janssen Global Services Corporation Information
11.1.2 Janssen Global Services Description, Business Overview and Total Revenue
11.1.3 Janssen Global Services Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Janssen Global Services Treatment for Gastroparesis Products Offered
11.1.5 Janssen Global Services Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Treatment for Gastroparesis Market Estimates and Projections by Region
12.1.1 Global Treatment for Gastroparesis Sales Forecast by Regions 2021-2026
12.1.2 Global Treatment for Gastroparesis Revenue Forecast by Regions 2021-2026
12.2 North America Treatment for Gastroparesis Market Size Forecast (2021-2026)
12.2.1 North America: Treatment for Gastroparesis Sales Forecast (2021-2026)
12.2.2 North America: Treatment for Gastroparesis Revenue Forecast (2021-2026)
12.2.3 North America: Treatment for Gastroparesis Market Size Forecast by Country (2021-2026)
12.3 Europe Treatment for Gastroparesis Market Size Forecast (2021-2026)
12.3.1 Europe: Treatment for Gastroparesis Sales Forecast (2021-2026)
12.3.2 Europe: Treatment for Gastroparesis Revenue Forecast (2021-2026)
12.3.3 Europe: Treatment for Gastroparesis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Treatment for Gastroparesis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Treatment for Gastroparesis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Treatment for Gastroparesis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Treatment for Gastroparesis Market Size Forecast by Region (2021-2026)
12.5 Latin America Treatment for Gastroparesis Market Size Forecast (2021-2026)
12.5.1 Latin America: Treatment for Gastroparesis Sales Forecast (2021-2026)
12.5.2 Latin America: Treatment for Gastroparesis Revenue Forecast (2021-2026)
12.5.3 Latin America: Treatment for Gastroparesis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Treatment for Gastroparesis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Treatment for Gastroparesis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Treatment for Gastroparesis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Treatment for Gastroparesis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Treatment for Gastroparesis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Treatment for Gastroparesis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
